Transparency Market Research discusses the latest trends in DNA chips and their consequences on the market’s futures in “DNA Chip Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023.” A simplified and segmented analysis will help explain the good, the bad, and the opportunities in the global DNA chip market for the coming years.
Download Complete Healthcare Analytical Brochure: http://bit.ly/2ien9wN
The primary factor attributed to the growth of the global DNA chip market currently is growing demand for personalized medicine. The role of DNA chips in personalized medicine is revolutionary and will help improve drug dosage rates to patients in a highly customized manner, as doctors or medical personnel will be able to access a patient’s medical records almost immediately. Another factor urging the growth of the global DNA chip market is the increasing prevalence of cancer. The growing number of cancer patients are easier to treat and document through the use of DNA chips. Seeing the massive advantages that DNA chips are bringing to the field of healthcare, organizations have stepped in to boost the investment ratios in the global DNA chip market.
The use of a DNA chip is advantageous in medical research as it helps bring down research time by a considerable amount. A DNA chip is a microarray that is made by embedding DNA spots on a solid surface, much like a computer chip. The growing use of DNA chips is thus a boon for drug development companies. They help medical researchers simultaneously measure the genetic expressions of a large number of genes over a fraction of the time taken without DNA chips.
The two common types of chips offered by the global DNA chip market are the oligonucleotide DNA chip and the complementary DNA chip. oDNA chips are extremely popular and had taken up close to 95% of the global DNA chip market over the recent years. Based on applications, the global DNA chip market can be segmented into geneID, gene expression profiling, comparative genomic hybridization, and others. Gene expression profiling has been the leading application segment for the global DNA chip market so far, owing to its use in the fields of clinical diagnostics and agriculture. It is also expected to show an optimistic growth rate over the coming years due to growing investments made into it.
North America had been the leading regional segment in the global DNA chip market over the past few years. This regions is, however, expected to reach maturity very soon and start losing market share to the emerging economies, where this market is aggressively expanding due to the massive scope of opportunities available.
The key players in the global DNA chip market include Affymetrix, Inc., Agilent Technologies, Biomérieux SA, Greiner Bio-One, Roche Nimblegen Inc., Lc Sciences, Scienion AG, Sigma-Aldrich, Savyon Diagnostics Ltd., Life Technologies Corporation, Sequenom Inc., Capitalbio Corporation, Bioneer Corporation, Microarrays Inc., Macrogen Inc., Biometrix Technology Inc., Eurofins Mwg Operon, Illumina Inc., and Wafergen Biosystems Inc.
Browse Full Research Report on DNA Chip Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.